Breaking News Instant updates and real-time market news.

CLXT

Calyxt

$10.37

-0.02 (-0.19%)

16:33
01/03/19
01/03
16:33
01/03/19
16:33

Calyxt appoints William Koschak as CFO

Calyxt announced the hiring of William Koschak, as CFO of Calyxt, effective January 7. Koschak will be assuming the responsibilities of current interim CFO, Eric Dutang, who remains CFO of Cellectis, Calyxt's parent company.

CLXT Calyxt
$10.37

-0.02 (-0.19%)

12/17/18
12/17/18
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) upgraded to Buy from Hold at Deutsche Bank with analyst Nicole DeBlase saying she believes the tariffs headwinds facing the company are easing. 2. Calyxt (CLXT) upgraded to Buy from Neutral at Goldman Sachs analyst Adam Samuelson saying the shares are down 42% since his September 7 initiation "despite several positive developments as the company approaches commercialization." 3. Scotts Miracle-Gro (SMG) upgraded to Outperform from Market Perform at Raymond James. 4. Lululemon (LULU) upgraded to Buy from Hold at Stifel with analyst Jim Duffy saying while Lululemon's comps will "inevitably slow against difficult compares," its double-digit revenue growth can continue. 5. Barnes & Noble (BKS) upgraded to Buy from Hold at Craig-Hallum analyst Alex Fuhrman saying initial Q4 checks have indicated improved results, continued cost controls and better holiday sales results, which, combined with the ongoing sales process, should provide "intriguing" upside potential. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/16/18
GSCO
12/16/18
UPGRADE
Target $18
GSCO
Buy
Goldman upgrades Calyxt to Buy with $18 target after 42% selloff
Goldman Sachs analyst Adam Samuelson upgraded Calyxt to Buy from Neutral with an unchanged price target of $18. The stock closed Friday up 43c to $9.88. The analyst says the shares are down 42% since his September 7 initiation "despite several positive developments as the company approaches commercialization." Calyxt has hired a new CEO with agriculture chemistry/seed experience, signed multiple agreements with U.S. soybean crushers and refiners to support the launch of its High Oleic Soybean platform in 2019, and confirmed "strong" yields on its 2018 soybean crop, Samuelson tells investors in a research note. He sees an improved risk/reward in shares as well as an attractive longer-term entry point.
12/16/18
GSCO
12/16/18
UPGRADE
GSCO
Buy
Calyxt upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs upgrades Calyxt to Buy, saying underperformance presents opportunity as commercial sales approach.
09/07/18
09/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sonic (SONC) initiated with an Outperform at Wedbush. 2. Molson Coors (TAP) initiated with an Underperform at Jefferies while Constellation Brands (STZ) was initiated with a Buy at Jefferies. 3. Amalgamated Bank (AMAL) initiated with an Outperform at Raymond James. 4. NXP Semiconductors (NXPI) initiated with an Outperform at Cowen. 5. Calyxt (CLXT) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MNK

Mallinckrodt

$2.94

-0.165 (-5.31%)

15:37
11/11/19
11/11
15:37
11/11/19
15:37
Hot Stocks
Mallinckrodt says Phase 3 CONFIRM study met primary endpoint »

Mallinckrodt announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

FGEN

FibroGen

$35.69

-5.92 (-14.23%)

15:34
11/11/19
11/11
15:34
11/11/19
15:34
Options
FibroGen options imply 13.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

FNV

Franco-Nevada

$95.70

0.09 (0.09%)

15:19
11/11/19
11/11
15:19
11/11/19
15:19
Options
Franco-Nevada options imply 4.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MNST

Monster Beverage

$57.81

-0.38 (-0.65%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Recommendations
Monster Beverage analyst commentary  »

Monster Beverage said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/11/19
11/11
15:16
11/11/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$29.63

-0.45 (-1.50%)

15:04
11/11/19
11/11
15:04
11/11/19
15:04
Options
DXC Technology options imply 23.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

MRK

Merck

$83.09

-0.5 (-0.60%)

15:01
11/11/19
11/11
15:01
11/11/19
15:01
Hot Stocks
Merck reports ERVEBO vaccine granted conditional approval in EU »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

BTI

British American Tobacco

$37.41

0.38 (1.03%)

, MO

Altria Group

$46.49

0.08 (0.17%)

14:51
11/11/19
11/11
14:51
11/11/19
14:51
Hot Stocks
Trump says will meet with representatives of the vaping industry »

U.S. President Donald…

BTI

British American Tobacco

$37.41

0.38 (1.03%)

MO

Altria Group

$46.49

0.08 (0.17%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$83.70

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

WMGI

Wright Medical

$29.39

-0.01 (-0.03%)

14:49
11/11/19
11/11
14:49
11/11/19
14:49
Options
Wright Medical options imply 3.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$17.86

-0.515 (-2.80%)

14:45
11/11/19
11/11
14:45
11/11/19
14:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change at Ladenburg »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$185.80

-1.31 (-0.70%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Recommendations
Alibaba analyst commentary at Raymond James »

Alibaba Singles Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.